Name | Conc.a | IC50 | |
---|---|---|---|
Bilirubin Glucuronidation (Effect) | Estradiol-3-Glucuronidation (Effect) | ||
μM | |||
Ritonavir | 1.3–50 | 3.0 (inhibition) | 1.7 (inhibition) |
Anthraflavic acid | 2–40 | 3.6 (inhibition) | 4.0 (inhibition) |
Levothyroxine | 0.6–10 | 4.9 (inhibition) | 5.6 (inhibition) |
Baicalein | 0.5–10 | 7.0 (inhibition) | 4.4 (inhibition) |
Farnesol | 13–60 | 47 (inhibition) | 40 (inhibition) |
4-Methylumbelliferone | 28–550 | 100 (inhibition) | 100 (inhibition) |
4′-OH-phenytoin | 15–300 | 120 (inhibition) | 110 (inhibition) |
Raltegravir | 25–200 | 170 (inhibition) | 190 (inhibition) |
Riluzole | 25–500 | 180 (inhibition) | 160 (inhibition) |
1-Naphthol | 88–1700 | 240 (inhibition) | 280 (inhibition) |
Ketoconazole | 6.3–100 | 27 (inhibition) | 13 (inhibition) |
Carvedilol | 2.5–50 | 27 (inhibition) | 12 (inhibition) |
Niflumic acid | 2–80 | 53 (inhibition) | 13 (inhibition) |
SN-38 | 6.3–400 | 360 (inhibition) | N.A. (partial inhibition) |
Ethinylestradiol | 2.5–50 | 21 (inhibition) | 44 (activation and inhibition) |
Daidzein | 6.3–130 | 7.3 (inhibition) | 120 (activation and inhibition) |
↵a Concentration ranges of the modifiers used for IC50 determination.